Correct Answer: C. Female pseudohermaphroditism
Congenital adrenal hyperplasia (CAH) most commonly presents as female pseudohermaphroditism because the pathophysiology involves excessive androgen production in utero. In 21-hydroxylase deficiency—the most common form (90–95% of CAH cases)—the enzyme block prevents cortisol synthesis, causing shunting of precursors into the androgen pathway. Genetically female (46,XX) fetuses are exposed to high intrauterine androgen levels, leading to virilization of external genitalia while internal female structures (uterus, ovaries) remain normal. This defines pseudohermaphroditism: discordance between gonadal sex (female) and phenotypic sex (virilized external genitalia). The degree of virilization ranges from mild clitoromegaly to complete masculinization (Prader stages I–V). Genetic males (46,XY) with CAH have normally virilized external genitalia and are typically diagnosed later through salt-wasting crisis or precocious puberty. True hermaphroditism and male pseudohermaphroditism are rare and unrelated to CAH pathophysiology. In Indian pediatric practice, CAH is screened via newborn screening programs and presents acutely with salt-wasting crisis (hyponatremia, hyperkalemia, shock) in the first 2–4 weeks of life, often before virilization is recognized in females.
Why the other options are wrong
A. 46, XY intersex — This is wrong because 46,XY intersex (formerly male pseudohermaphroditism) is not the typical presentation of CAH. Genetic males with CAH have normal testicular development and normally virilized external genitalia; they lack the gonadal-phenotypic discordance that defines intersex. Males present later with salt-wasting crisis or precocious puberty, not ambiguous genitalia. This option confuses the sex chromosome karyotype with the clinical phenotype. B. Male pseudohermaphroditism — This is wrong because male pseudohermaphroditism refers to 46,XY individuals with undervirilization of external genitalia due to androgen insensitivity or defective androgen synthesis (e.g., 17β-HSD deficiency, 5α-reductase deficiency). CAH in males does not cause undervirilization; it causes normal or excessive virilization. This is a classic NBE trap pairing CAH with 'pseudohermaphroditism' without specifying the sex. D. True hermaphroditism — This is wrong because true hermaphroditism (presence of both ovarian and testicular tissue in the same individual) is a rare disorder of gonadal development unrelated to CAH pathophysiology. CAH does not affect gonadal differentiation; it only affects adrenal steroid synthesis. True hermaphroditism is associated with chimeric karyotypes (45,X/46,XY) or mosaicism, not with enzyme defects in the adrenal cortex.
High-Yield Facts
- 21-hydroxylase deficiency accounts for 90–95% of CAH cases and causes female pseudohermaphroditism via intrauterine androgen excess.
- Female pseudohermaphroditism in CAH: 46,XX karyotype with virilized external genitalia but normal internal female structures (uterus, ovaries, fallopian tubes).
- Prader staging (I–V) quantifies virilization severity in CAH females, from mild clitoromegaly (I) to complete masculinization (V).
- Salt-wasting CAH presents at 2–4 weeks of age with hyponatremia, hyperkalemia, and shock; non-salt-wasting form presents with virilization or precocious puberty.
- Genetic males with CAH have normal external genitalia and are diagnosed via salt-wasting crisis or precocious puberty, not intersex presentation.
- 11β-hydroxylase deficiency (5% of CAH) causes hypertension and hypokalemia due to excess 11-deoxycortisol and aldosterone, but still presents as female pseudohermaphroditism.
Mnemonics
CAH + XX = Virilization (Female Pseudohermaphroditism) 46,XX + adrenal androgens → virilized external genitalia + normal internal female organs = female pseudohermaphroditism. Remember: the adrenal makes excess androgens, not the gonads. SALT-WASTING CAH: HypoNa, HyperK, SHOCK Salt-wasting CAH (75% of classic CAH) → aldosterone deficiency → sodium loss, potassium retention, hypovolemic shock at 2–4 weeks. Non-salt-wasting form presents with virilization alone.
NBE Trap
NBE pairs 'pseudohermaphroditism' with CAH and expects students to reflexively choose 'male' pseudohermaphroditism without considering that CAH causes female pseudohermaphroditism (46,XX with virilization). The trap exploits confusion between the sex chromosome karyotype and the phenotypic presentation.
Clinical Pearl
In Indian pediatric practice, a newborn girl with ambiguous genitalia presenting at 2–4 weeks with hyponatremia and shock is CAH until proven otherwise. Immediate management includes IV fluids, hydrocortisone, and fludrocortisone; delayed diagnosis risks mortality. Genetic counseling is essential for recurrence risk (25% in autosomal recessive inheritance).
_Reference: OP Ghai Pediatrics Ch. 9 (Endocrine Disorders); Harrison Ch. 401 (Disorders of Sex Development)_